See also this year's filing and all EDGAR filings for this company.
PDF Report 0001119643_2013_Nutra_Pharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 4348810, 'size_variable': 'Assets', 'size_value': 129361, 'ratio': 33.6, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001119643')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001119643, Nutra Pharma CORP
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 3,879,220 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 246,741 |
| 4 | AssetsNoncurrent | 16,621 |
| 5 | PropertyPlantAndEquipmentNet | 39,515 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 2,801,343 |
| 9 | ResearchAndDevelopmentExpense | 3,046 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 203,290 |
| 12 | remainder_NetIncome | -1,011,252 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 3,879,220 |
| 1 | Assets | 302,877 |
| 2 | Expenses | 2,804,389 |
| 3 | Revenues | 203,290 |
| 4 | StockholdersEquity | -3,576,343 |
| 5 | NetIncome | -3,612,351 |
| 6 | ComprehensiveNetIncome | -3,612,351 |
| 7 | BaseVar | 4,100,514 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.07 |
| 9 | EconomicCapitalRatio | 0.0213 |
Edgar->Model Mapping
Feature Distribution
Change over Time
